Leidos Holdings, Inc. (NYSE:LDOS) Q2 2023 Earnings Call Transcript

Page 8 of 10

Seth Seifman: Great. Thanks. I’ll stick to one this morning.

Operator: Our next questions are from the line of Robert Spingarn with Melius Research. Please proceed with your question.

Robert Spingarn: Hey, good morning. Just following on that – hey, good morning, everybody, and welcome, Tom. On 2024, just with regard to the budget and the difference between the budget caps from the debt ceiling deal on the defense budget, and then on non-defense where there’s going to be decreases, given that you have a couple of segments that point away from defense. Do you just broaden the aperture there so that your pipeline can offset potential pressure on the budget?

Tom Bell: Yes, you’re right, there is a curious dynamic that’s been set up as a result of the debt ceiling debate and resolution that occurred, that obviously people on Capitol Hill are expressing optimism that they will solve before we’re facing another government shutdown. At the same time, we’re actively working with all of our customers on both sides of that equilibrium, if you will, to ensure that if there are things we can do this year to get them out of harm’s way of any possible budget challenges they might face next year, we’re engaged with them on that. And we’re also focusing on exactly what you suggest, Robert, which is expanding the areas where we can help those customers and/or customers like them. So, I’m not overly concerned about 2024 and the law of unintended consequences, if you will.

I’m very focused on the fact that the team is engaged with customers about all those eventualities, and we feel we’re fairly insulated against near-term impacts from any possible government shutdown. Chris?

Chris Cage: Yes, Rob, I mean, there’s certainly areas within our Civil and Health business that we’ve been positioning to make sure we’re in priority areas for our customers. We just talked a bit about the VBA side and that’s not going to change. But outside of the civilian agencies, I mean, you look at what we do in our commercial energy business, and grid resiliency and critical infrastructure, and those are areas that you’re going to see more spending dedicated to. So, the team’s really been doing an excellent job there. And obviously, we’ve been talking a lot about security products in the pipeline and opportunities there. So, there are definitely parts of the portfolio that we will have strong budgetary environments, we believe, and we’ll prioritize those in the near-term. And as Tom mentioned, we’re optimistic that we’ll weather any challenges in certain customer areas.

Robert Spingarn: Chris, just on that last part, when we think about healthcare and discretionary versus non-discretionary funding, so Medicare, Medicaid and so on. Is there a way to quantify what portion of your healthcare business gets funded out of those non-discretionary budgets?

Chris Cage: Well, a lot of the stuff that we’re doing on the medical examination businesses is in that bucket, right? So, we know that’s well protected and insulated. And then, obviously the health record modernization programs are priorities for our customer sets and what we’re doing on Reserve Health Readiness. So, I think by and large, Rob, we’re in a good position there, but that’ll be something we can come back with details on in the future.

Robert Spingarn: Great. Thanks so much.

Operator: The next question is from the line of Toby Sommer with Truist Securities. Please proceed with your questions.

Jasper Bibb: Hey, good morning. This is Jasper Bibb on for Toby. Just wanted to ask about the security products business and underperformance versus the acquisition case there. Would there be any way to quantify what getting that business back up to your targets might mean for Civil segment revenue growth and margins over the next few years?

Page 8 of 10